Table II.
Disease characteristics
| Characteristic | n (%)a |
|---|---|
| Asthma severity classification at baseline (n = 91) | |
| Intermittent | 6 (6.6) |
| Mild persistent | 30 (33.0) |
| Moderate persistent | 41 (45.1) |
| Severe persistent | 14 (15.4) |
| Asthma medications in last wk (n = 89) | |
| ICS alone or with LA | 5 (5.6) |
| BD with ICS or BD with LA | 46 (51.7) |
| BD plus ICS plus LA | 34 (38.2) |
| Oral steroid alone or with any other asthma medication | 4 (4.5) |
| Physician baseline global asthma control assessment (n = 91) [mean (SD)] | 2.3 (1.1) |
| Number of asthma attacks since baselineb (n = 64) | |
| None | 28 (43.8) |
| One | 19 (29.7) |
| Two or more | 17 (26.7) |
| Number of visits to ED for urgent asthma treatment since baseline (n = 64) | |
| None | 57 (89.1) |
| One or more | 7 (11.0) |
| Number of unscheduled visits to doctor’s office or walk-in clinic for urgent asthma treatment since baseline (n = 64) | |
| None | 58 (90.6) |
| One or more | 6 (9.5) |
| Number of school days missed because of asthma since baseline (n = 64) | |
| None | 36 (56.3) |
| One | 8 (12.5) |
| Two | 7 (10.9) |
| Three or more | 13 (20.3) |
a
Unless otherwise indicated.
b
An asthma attack is defined as the sudden worsening of symptoms that results in difficulty breathing and may require taking additional medication. It may or may not require a visit to an ED or a doctor.
BD = bronchodilator; ICS = inhaled corticosteroid; LA = leukotriene antagonist; SD = standard deviation.